Evidence map›Paper›PMID 33247203›Full record

ArticleScientific reports2020

Quantifying the contribution of established risk factors to cardiovascular mortality differences between Russia and Norway.

Sergi Trias-Llimós, Lisa Pennells, Aage Tverdal, Alexander V Kudryavtsev, Sofia Malyutina, Laila A Hopstock, Olena Iakunchykova, Yuri Nikitin, Per Magnus, Stephen Kaptoge and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sergi Trias-LlimósDepartment of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. sergi.trias-llimos@lshtm.ac.uk.
Lisa PennellsDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Aage TverdalCentre for Fertility and Health, Norwegian Insitute of Public Health, Oslo, Norway.
Alexander V KudryavtsevCentral Scientific Research Laboratory, Northern State Medical University, Arkhangelsk, Russia.
Sofia MalyutinaResearch Institute of Internal and Preventive Medicine-Branch of IC&G, SB RAS, Novosibirsk, Russia.
Laila A HopstockDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Olena IakunchykovaDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Yuri NikitinResearch Institute of Internal and Preventive Medicine-Branch of IC&G, SB RAS, Novosibirsk, Russia.
Per MagnusCentre for Fertility and Health, Norwegian Insitute of Public Health, Oslo, Norway.
Stephen KaptogeDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Emanuele Di AngelantonioDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
David A LeonDepartment of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

Funding

British Heart Foundation CH/12/2/29428British Heart Foundation RG/13/13/30194Medical Research Council MR/L003120/1Wellcome TrustWellcome Trust 100217
6 · The paper itself

Abstract

Surprisingly few attempts have been made to quantify the simultaneous contribution of well-established risk factors to CVD mortality differences between countries. We aimed to develop and critically appraise an approach to doing so, applying it to the substantial CVD mortality gap between Russia and Norway using survey data in three cities and mortality risks from the Emerging Risk Factor Collaboration. We estimated the absolute and relative differences in CVD mortality at ages 40-69 years between countries attributable to the risk factors, under the counterfactual that the age- and sex-specific risk factor profile in Russia was as in Norway, and vice-versa. Under the counterfactual that Russia had the Norwegian risk factor profile, the absolute age-standardized CVD mortality gap would decline by 33.3% (95% CI 25.1-40.1) among men and 22.1% (10.4-31.3) among women. In relative terms, the mortality rate ratio (Russia/Norway) would decline from 9-10 to 7-8. Under the counterfactual that Norway had the Russian risk factor profile, the mortality gap reduced less. Well-established CVD risk factors account for a third of the male and around a quarter of the female CVD mortality gap between Russia and Norway. However, these estimates are based on widely held epidemiological assumptions that deserve further scrutiny.

Indexed as

AdultAgedBlood PressureCardiovascular DiseasesCholesterolDiabetes ComplicationsFemaleHumansHypercholesterolemiaHypertensionMaleMiddle AgedNorwayPrevalenceRisk FactorsRussiaCholesterol

Identifiers

PMID33247203
PMCPMC7695740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.